Healthcare & Life Sciences
Artiva Biotherapeutics
United Stateswww.artivabio.com
Artiva Biotherapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2018
Founded
2
Investors
About Artiva Biotherapeutics
Based in the United States, Artiva Biotherapeutics is a startup founded in 2018. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Artiva Biotherapeutics develops off-the-shelf natural killer (NK) cell-based immunotherapies for cancer, including engineered and CAR-NK products intended to provide scalable allogeneic cell therapy options.
Explore Artiva Biotherapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.